Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy.

A review on pathophysiology of irritable bowel syndrome with emphasis on the role of brain factors

Irritable bowel syndrome (IBS) is a common and chronic functional gastrointestinal disorder that causes a great burden on the individual and society. Despite many studies, there is no consent about the etiology, diagnostic and treatment method of IBS. In recent years, neurologic factors have been given attention for better understanding and management of this disorder. The aim of the present st...

Atrial Fibrillation: The Science behind Its Defiance

Atrial fibrillation (AF) is the most prevalent arrhythmia in the world, due both to its tenacious treatment resistance, and to the tremendous number of risk factors that set the stage for the atria to fibrillate. Cardiopulmonary, behavioral, and psychological risk factors generate electrical and structural alterations of the atria that promote reentry and wavebreak. These culminate in fibrillat...

Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system.

[Atrial fibrillation and the autonomic nervous system].

The autonomic nervous system plays an important role in the genesis of various cardiac rhythm disorders. Experimental studies have indicated that in atrial fibrillation particularly vagal activity may have a decisive influence on the electrophysiologic properties of atrial myocardium. In patients with paroxysmal atrial fibrillation, a carefully taken history and electrocardiographic findings ob...

Effect of Yoga on the Autonomic Nervous System: Clinical Implications in the Management of Atrial Fibrillation

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is seen in approximately 1.5% of the U.S. population [1] and results in substantial morbidity and mortality [2]. One of the largest U.S. epidemiological studies, the Framingham Heart Study, predicted that AF prevalence doubles with each advancing decade of age, from 0.5% at age 50-59 years to almost 9% at age 80-89 years, i...